Alternatives to Genexine
Genexine is a Biotechnology tool: south Korean biopharmaceutical company developing novel biologics for cancer and rare diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Genexine
- Website
Travere Therapeutics51BiotechnologySan Diego, USA$63.0MA biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website
LTZ Therapeutics49BiotechnologyRedwood City, USA$76.0MImmunotherapy company targeting oncology and autoimmune diseases.
- Website
Brenus Pharma48BiotechnologyLyon, France$12.6MClinical-stage immunotherapy company developing novel treatments for cancer.
- Website
Signadori Bio45BiotechnologyParis, France$12.2MDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
4D Path59BiotechnologyNewton, USA$17.4MPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
- Website
ImmunoScape58BiotechnologySingapore, Singapore$49.7MDeveloping novel immunotherapies and diagnostics for cancer.
- Website
Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8MA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Showing the 20 closest matches. See the rest on the Genexine profile.
Compare Genexine head to head
Side by side on what each one does, what it costs, and what real users report.